Vivek Reddy, MD
Vascular Neurology · Salt Lake City, UTNPI 1437376571
Payments from drug & device makers
Across 22 payments — averaging $3114.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$58K
- Abbott$10K
- Boston Scientific$304
- Medtronic$69
Across 3 payments — averaging $711.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
What the payments were for
- Travel & lodging$9,27688%
- Food & beverage$1,21312%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 3 | $58,023 |
| Abbott | 16 | $10,117 |
| Boston Scientific | 2 | $304 |
| Medtronic | 1 | $69 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$8,987
- FLEXABILITY$272
- EnSite Precision Cardiac Mapping System$168
- Farapulse$162
- WATCHMAN Access System$142
How this compares
Too few vascular neurology providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $63,886 |
| Nurtec OdtRimegepant Sulfate | 18 | $26,688 |
| Repatha SureclickEvolocumab | 35 | $21,460 |
| XareltoRivaroxaban | 12 | $11,032 |
| Lacosamide | 25 | $4,209 |
| Levetiracetam | 50 | $1,163 |
| Baclofen | 31 | $914 |
| Pregabalin | 24 | $740 |
| Rosuvastatin Calcium | 39 | $565 |
| Atorvastatin Calcium | 47 | $451 |
| Gabapentin | 30 | $350 |
| Donepezil Hcl | 52 | $348 |
| Lamotrigine | 24 | $340 |
| Cilostazol | 13 | $323 |
| Ezetimibe | 16 | $268 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Salt Lake City
- Lee ChungSalt Lake City$123K
- Matthew GrantzSalt Lake City$400
- Brian MarcusSalt Lake City$236
- Yarden BornovskiSalt Lake City$144
- Stephanie LydenSalt Lake City$0
- Kyle HobbsMurray$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.